The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 119.52%.However, over the last six months, we can see a stronger performance of -44.54%. Over the last 30 days, the price of CAPR has fallen by 2.29%. And in the last five days, it has surged by 1.76%.
At present, Capricor Therapeutics Inc (CAPR) has a stock price of $7.82. In the previous session, the stock saw a rise, peaking at $29.0 after an opening price of $7.82. The day’s lowest price was $12.0, and it closed at $9.07.
Capricor Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $23.40 on 10/15/24, while the lowest price for the same duration was marked at $3.71 on 08/12/24.
52-week price history of CAPR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Capricor Therapeutics Inc’s current trading price is -66.60% away from its 52-week high, while its distance from the 52-week low is 110.70%. The stock’s price range during this period has varied between$3.71 and $23.40. The Capricor Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.2 million for the day, a figure considerably lower than their average daily volume of 2.87 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Capricor Therapeutics Inc (CAPR) has experienced a quarterly rise of 23.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 357.21M and boasts a workforce of 160 employees.
Capricor Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 7 analysts are rating Capricor Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.02, with a change in price of -3.79. Similarly, Capricor Therapeutics Inc recorded 2,520,799 in trading volume during the last 100 days, posting a change of -32.69%.
CAPR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
CAPR Stock Stochastic Average
As of today, Capricor Therapeutics Inc’s raw stochastic average for the last 50 days stands at 19.54%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 50.15%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 71.52% and 59.83%, respectively.
